WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease

Year of Publication

Issuing Institution

Recommendations

17 included recommendations

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

Recommended in favor

Certainty of evidence

WHO consolidated guidelines on tuberculosis: module 2: screening: systematic screening for tuberculosis disease

Recommendations

Systematic screening for TB disease may be conducted among the general population in areas with an estimated TB prevalence of 0.5% or higher

People living with HIV should be systematically screened for TB disease at each visit to a health facility

Household contacts and other close contacts of individuals with TB disease, including women in the postpartum period and newborns, should be systematically screened for TB disease

Systematic screening for TB disease should be conducted in prisons and penitentiary institutions

Current and former workers in workplaces with silica exposure should be systematically screened for active TB

In settings where the TB prevalence in the general population is 100/100 000 population or higher, systematic screening for TB disease may be conducted among people with a risk factor for TB who are either seeking health care or who are already in care

People with an untreated fibrotic lesion seen on chest X-ray may be systematically screened for TB disease

Among individuals aged 15 years and older in populations in which TB screening is recommended, systematic screening for TB disease may be conducted using a symptom screen, chest X-ray or molecular WHO-recommended rapid diagnostic tests, alone or in combination

Among individuals aged 15 years and older in populations in which TB screening is recommended, computer-aided detection software programmes may be used in place of human readers for interpreting digital chest X-rays for screening and triage for TB disease

Among adults and adolescents living with HIV, C-reactive protein with a cut-off of > 5 mg/L may be used to screen for TB disease

Among adults and adolescents living with HIV, chest X-ray may be used to screen for TB disease

Among adults and adolescents living with HIV, molecular WHO-recommended rapid diagnostic tests may be used to screen for TB disease

Adult and adolescent inpatients with HIV in medical wards where the TB prevalence is > 10% should be tested systematically for TB disease with a molecular WHO-recommended rapid diagnostic test

Among individuals younger than 15 years who are close contacts of someone with TB, systematic screening for TB disease should be conducted using a symptom screen including any one of cough, fever or poor weight gain; or chest radiography; or both

Among children younger than 10 years who are living with HIV, systematic screening for TB disease should be conducted using a symptom screen including any one of current cough, fever, poor weight gain or close contact with a TB patient